.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Teva
Novartis
McKinsey
Chinese Patent Office
Fish and Richardson
QuintilesIMS
UBS
Chubb

Generated: September 19, 2017

DrugPatentWatch Database Preview

Nostrum Labs Company Profile

« Back to Dashboard

What is the competitive landscape for NOSTRUM LABS, and what generic and branded alternatives to NOSTRUM LABS drugs are available?

NOSTRUM LABS has twenty-three approved drugs.

There is one tentative approval on NOSTRUM LABS drugs.

Summary for Applicant: Nostrum Labs

Patents:0
Tradenames:19
Ingredients:18
NDAs:23
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nostrum Labs Inc
PROMETHAZINE HYDROCHLORIDE
promethazine hydrochloride
SYRUP;ORAL040891-001Mar 13, 2009AARXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs
LAXILOSE
lactulose
SOLUTION;ORAL073686-001May 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
MORPHINE SULFATE
morphine sulfate
SOLUTION;ORAL204053-001Oct 6, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL074404-002May 14, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, CHEWABLE;ORAL204954-003Jan 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
CARISOPRODOL
carisoprodol
TABLET;ORAL207237-001May 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
ELIXOPHYLLIN
theophylline
SOLUTION, ELIXIR;ORAL085186-001Approved Prior to Jan 1, 1982AARXNoYes► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
PINDOLOL
pindolol
TABLET;ORAL205415-001Jan 13, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
METHYLPHENIDATE HYDROCHLORIDE
methylphenidate hydrochloride
TABLET, CHEWABLE;ORAL204954-002Jan 26, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
VENLAFAXINE HYDROCHLORIDE
venlafaxine hydrochloride
TABLET, EXTENDED RELEASE;ORAL205468-002Mar 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Fuji
Teva
Queensland Health
Deloitte
Federal Trade Commission
Chinese Patent Office
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot